Serial #79252979
LIVE

Serial Number

79252979

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 19, 2018

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79252979 Trademark

Serial Number: 79252979 • Registration: 5837048

Serial #79252979 is a trademark filed by NOVARTIS AG on December 19, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 19, 2018

Registration Date

August 20, 2019

Published for Opposition

June 4, 2019

Goods & Services

[ Anti-infectives; ] anti-inflammatories; [ antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system; [ pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; ] pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, [ the endocrine system, ] * and * the musculo-skeletal system [ and the genitourinary system ] ; [ pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; ] pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders [ ; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 7, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 7, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 7, 2025 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 6, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Jan 13, 2025 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 20, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 3, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2019 FICS
FINAL DISPOSITION PROCESSED
Dec 13, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2019 NONP
ASSIGNED TO LIE
Apr 26, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2019 CNSA
REFUSAL PROCESSED BY IB
Apr 6, 2019 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 27, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2019 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 12, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Mar 12, 2019 MAFR
NON-FINAL ACTION WRITTEN
Mar 11, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 6, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 28, 2019 REPR